Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

2579.1000 7.10 (0.28%)

NSE Sep 12, 2025 15:31 PM

25.99% Fall from 52W High

Volume: 58,267

Ajanta Pharma Ltd.

01 Feb 2022

2579.10

0.28%

Ajanta Pharma (BUY): Strong revenue growth but margins contract

Buy: Ajanta Pharma Ltd.

Target

BOB Capital Markets Ltd.

Q3 revenue up 12% YoY spurred by branded formulations business in India and Africa; US sales down 14% QoQ to US$ 22mn

Number of FII/FPI investors decreased from 385 to 371 in Jun 2025 qtr